HEADER HYDROLASE/HYDROLASE INHIBITOR 20-AUG-98 1BQY TITLE PLASMINOGEN ACTIVATOR (TSV-PA) FROM SNAKE VENOM COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMINOGEN ACTIVATOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TSV-PA; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: VIRIDOVIPERA STEJNEGERI; SOURCE 3 ORGANISM_COMMON: STEJNEGER'S PIT VIPER; SOURCE 4 ORGANISM_TAXID: 39682; SOURCE 5 ORGAN: VENOM GLAND; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET KEYWDS FIBRINOLYSIS, PLASMINOGEN ACTIVATOR, SERINE PROTEINASE, SNAKE VENOM, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR M.A.A.PARRY,W.BODE REVDAT 6 30-OCT-24 1BQY 1 REMARK REVDAT 5 09-AUG-23 1BQY 1 REMARK LINK REVDAT 4 13-JUL-11 1BQY 1 VERSN REVDAT 3 24-FEB-09 1BQY 1 VERSN REVDAT 2 08-DEC-99 1BQY 3 HETATM REVDAT 1 20-AUG-99 1BQY 0 JRNL AUTH M.A.PARRY,U.JACOB,R.HUBER,A.WISNER,C.BON,W.BODE JRNL TITL THE CRYSTAL STRUCTURE OF THE NOVEL SNAKE VENOM PLASMINOGEN JRNL TITL 2 ACTIVATOR TSV-PA: A PROTOTYPE STRUCTURE FOR SNAKE VENOM JRNL TITL 3 SERINE PROTEINASES. JRNL REF STRUCTURE V. 6 1195 1998 JRNL REFN ISSN 0969-2126 JRNL PMID 9753698 JRNL DOI 10.1016/S0969-2126(98)00119-1 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.8 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 17215 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 861 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3594 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 162 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.870 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : RESTRAINTS REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1BQY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000172014. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : APR-97 REMARK 200 TEMPERATURE (KELVIN) : 293.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : CU FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17988 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.44400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.8 REMARK 200 STARTING MODEL: PDB ENTRY 3PTB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.64500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.83500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.71000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.83500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.64500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.71000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 45.29000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -33.71000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 245.50500 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 95 CD CE NZ REMARK 480 LYS A 95A CG CD CE NZ REMARK 480 GLU A 98 CG CD OE1 OE2 REMARK 480 LYS A 148 CD CE NZ REMARK 480 GLU A 149 CD OE1 OE2 REMARK 480 GLN A 175 CG CD OE1 NE2 REMARK 480 HIS A 218 CG ND1 CD2 CE1 NE2 REMARK 480 LYS A 245A CD CE NZ REMARK 480 LYS B 95 CD CE NZ REMARK 480 LYS B 95A CG CD CE NZ REMARK 480 GLU B 98 CG CD OE1 OE2 REMARK 480 LYS B 148 CG CD CE NZ REMARK 480 ARG B 169 CZ NH1 NH2 REMARK 480 GLN B 175 CG CD OE1 NE2 REMARK 480 HIS B 218 CG ND1 CD2 CE1 NE2 REMARK 480 LYS B 245A CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 28 -4.06 -59.34 REMARK 500 HIS A 71 -82.57 -122.05 REMARK 500 ASP A 102 77.17 -68.41 REMARK 500 ALA A 119 147.97 -175.89 REMARK 500 GLU A 149 50.59 -90.95 REMARK 500 THR A 179 33.64 -85.34 REMARK 500 PHE A 193 3.90 84.14 REMARK 500 HIS B 27 42.79 -146.37 REMARK 500 LEU B 41 -58.48 -120.36 REMARK 500 HIS B 71 -86.27 -133.91 REMARK 500 TYR B 172 51.10 -112.03 REMARK 500 THR B 179 36.89 -86.95 REMARK 500 SER B 214 -66.22 -123.32 REMARK 500 LYS B 245A 6.75 -68.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE UNBOUND FORM OF THE INHIBITOR IS GLU-GLY-ARG-CMK- REMARK 600 CHLOROMETHYLKETONE. UPON REACTION WITH PROTEIN IT FORMS TWO REMARK 600 COVALENT BONDS: 1) A COVALENT BOND TO SER 195 FORMING A HEMIKETAL REMARK 600 AR7 AND 2) A COVALENT BOND TO NE2 OF HIS 57. RESIDUE GLU OF THE REMARK 600 INHIBITOR IS MODELED WITH ZERO OCCUPANCY. REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 0GJ A 1 REMARK 615 0GJ B 1 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: L-ALPHA-GLUTAMYL-N-{(1S)-4-{[AMINO(IMINIO)METHYL] REMARK 630 AMINO}-1-[(1S)-2-CHLORO-1-HYDROXYETHYL]BUTYL}GLYCINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0GJ A 1 REMARK 630 0GJ B 1 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: GLU GLY AR7 0QE REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0GJ A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0GJ B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: A REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE IN CHAIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: B REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE IN CHAIN B DBREF 1BQY A 16 245 PIR A57290 A57290 25 258 DBREF 1BQY B 16 245 PIR A57290 A57290 25 258 SEQRES 1 A 234 VAL PHE GLY GLY ASP GLU CYS ASN ILE ASN GLU HIS ARG SEQRES 2 A 234 SER LEU VAL VAL LEU PHE ASN SER ASN GLY PHE LEU CYS SEQRES 3 A 234 GLY GLY THR LEU ILE ASN GLN ASP TRP VAL VAL THR ALA SEQRES 4 A 234 ALA HIS CYS ASP SER ASN ASN PHE GLN LEU LEU PHE GLY SEQRES 5 A 234 VAL HIS SER LYS LYS ILE LEU ASN GLU ASP GLU GLN THR SEQRES 6 A 234 ARG ASP PRO LYS GLU LYS PHE PHE CYS PRO ASN ARG LYS SEQRES 7 A 234 LYS ASP ASP GLU VAL ASP LYS ASP ILE MET LEU ILE LYS SEQRES 8 A 234 LEU ASP SER SER VAL SER ASN SER GLU HIS ILE ALA PRO SEQRES 9 A 234 LEU SER LEU PRO SER SER PRO PRO SER VAL GLY SER VAL SEQRES 10 A 234 CYS ARG ILE MET GLY TRP GLY LYS THR ILE PRO THR LYS SEQRES 11 A 234 GLU ILE TYR PRO ASP VAL PRO HIS CYS ALA ASN ILE ASN SEQRES 12 A 234 ILE LEU ASP HIS ALA VAL CYS ARG THR ALA TYR SER TRP SEQRES 13 A 234 ARG GLN VAL ALA ASN THR THR LEU CYS ALA GLY ILE LEU SEQRES 14 A 234 GLN GLY GLY ARG ASP THR CYS HIS PHE ASP SER GLY GLY SEQRES 15 A 234 PRO LEU ILE CYS ASN GLY ILE PHE GLN GLY ILE VAL SER SEQRES 16 A 234 TRP GLY GLY HIS PRO CYS GLY GLN PRO GLY GLU PRO GLY SEQRES 17 A 234 VAL TYR THR LYS VAL PHE ASP TYR LEU ASP TRP ILE LYS SEQRES 18 A 234 SER ILE ILE ALA GLY ASN LYS ASP ALA THR CYS PRO PRO SEQRES 1 B 234 VAL PHE GLY GLY ASP GLU CYS ASN ILE ASN GLU HIS ARG SEQRES 2 B 234 SER LEU VAL VAL LEU PHE ASN SER ASN GLY PHE LEU CYS SEQRES 3 B 234 GLY GLY THR LEU ILE ASN GLN ASP TRP VAL VAL THR ALA SEQRES 4 B 234 ALA HIS CYS ASP SER ASN ASN PHE GLN LEU LEU PHE GLY SEQRES 5 B 234 VAL HIS SER LYS LYS ILE LEU ASN GLU ASP GLU GLN THR SEQRES 6 B 234 ARG ASP PRO LYS GLU LYS PHE PHE CYS PRO ASN ARG LYS SEQRES 7 B 234 LYS ASP ASP GLU VAL ASP LYS ASP ILE MET LEU ILE LYS SEQRES 8 B 234 LEU ASP SER SER VAL SER ASN SER GLU HIS ILE ALA PRO SEQRES 9 B 234 LEU SER LEU PRO SER SER PRO PRO SER VAL GLY SER VAL SEQRES 10 B 234 CYS ARG ILE MET GLY TRP GLY LYS THR ILE PRO THR LYS SEQRES 11 B 234 GLU ILE TYR PRO ASP VAL PRO HIS CYS ALA ASN ILE ASN SEQRES 12 B 234 ILE LEU ASP HIS ALA VAL CYS ARG THR ALA TYR SER TRP SEQRES 13 B 234 ARG GLN VAL ALA ASN THR THR LEU CYS ALA GLY ILE LEU SEQRES 14 B 234 GLN GLY GLY ARG ASP THR CYS HIS PHE ASP SER GLY GLY SEQRES 15 B 234 PRO LEU ILE CYS ASN GLY ILE PHE GLN GLY ILE VAL SER SEQRES 16 B 234 TRP GLY GLY HIS PRO CYS GLY GLN PRO GLY GLU PRO GLY SEQRES 17 B 234 VAL TYR THR LYS VAL PHE ASP TYR LEU ASP TRP ILE LYS SEQRES 18 B 234 SER ILE ILE ALA GLY ASN LYS ASP ALA THR CYS PRO PRO HET 0GJ A 1 25 HET 0GJ B 1 25 HETNAM 0GJ L-ALPHA-GLUTAMYL-N-{(1S)-4-{[AMINO(IMINIO) HETNAM 2 0GJ METHYL]AMINO}-1-[(1S)-2-CHLORO-1- HETNAM 3 0GJ HYDROXYETHYL]BUTYL}GLYCINAMIDE FORMUL 3 0GJ 2(C14 H28 CL N6 O5 1+) FORMUL 5 HOH *162(H2 O) HELIX 1 1 ALA A 56 CYS A 58 5 3 HELIX 2 2 HIS A 165 ALA A 171 1 7 HELIX 3 3 VAL A 231 ALA A 243 5 13 HELIX 4 4 ALA B 56 CYS B 58 5 3 HELIX 5 5 HIS B 165 ALA B 171 1 7 HELIX 6 6 VAL B 231 ALA B 243 5 13 SHEET 1 A 7 GLN A 81 ASP A 84 0 SHEET 2 A 7 GLN A 65 PHE A 68 -1 N PHE A 68 O GLN A 81 SHEET 3 A 7 LEU A 30 ASN A 35 -1 N PHE A 34 O GLN A 65 SHEET 4 A 7 GLY A 39 ASN A 48 -1 N GLY A 44 O VAL A 31 SHEET 5 A 7 TRP A 51 THR A 54 -1 N VAL A 53 O THR A 45 SHEET 6 A 7 MET A 104 LEU A 108 -1 N ILE A 106 O VAL A 52 SHEET 7 A 7 PRO A 85 PHE A 89 -1 N PHE A 89 O LEU A 105 SHEET 1 B 7 HIS A 156 ASN A 161 0 SHEET 2 B 7 VAL A 135 GLY A 140 -1 N GLY A 140 O HIS A 156 SHEET 3 B 7 PRO A 198 CYS A 201 -1 N ILE A 200 O ARG A 137 SHEET 4 B 7 ILE A 208 TRP A 215 -1 N GLY A 211 O LEU A 199 SHEET 5 B 7 GLY A 226 LYS A 230 -1 N THR A 229 O ILE A 212 SHEET 6 B 7 THR A 180 GLY A 184 -1 N ALA A 183 O GLY A 226 SHEET 7 B 7 ASN A 161 LEU A 163 -1 N LEU A 163 O CYS A 182 SHEET 1 C 4 GLN B 81 ASP B 84 0 SHEET 2 C 4 GLN B 65 PHE B 68 -1 N PHE B 68 O GLN B 81 SHEET 3 C 4 LEU B 30 ASN B 35 -1 N PHE B 34 O GLN B 65 SHEET 4 C 4 GLY B 39 THR B 45 -1 N GLY B 44 O VAL B 31 SHEET 1 D 3 TRP B 51 THR B 54 0 SHEET 2 D 3 MET B 104 LEU B 108 -1 N ILE B 106 O VAL B 52 SHEET 3 D 3 PRO B 85 PHE B 89 -1 N PHE B 89 O LEU B 105 SHEET 1 E 6 VAL B 135 GLY B 140 0 SHEET 2 E 6 HIS B 156 LEU B 163 -1 N ILE B 160 O CYS B 136 SHEET 3 E 6 THR B 180 GLY B 184 -1 N GLY B 184 O ASN B 161 SHEET 4 E 6 GLY B 226 LYS B 230 -1 N TYR B 228 O LEU B 181 SHEET 5 E 6 ILE B 208 TRP B 215 -1 N TRP B 215 O VAL B 227 SHEET 6 E 6 PRO B 198 CYS B 201 -1 N CYS B 201 O ILE B 208 SSBOND 1 CYS A 22 CYS A 157 1555 1555 2.03 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03 SSBOND 3 CYS A 91 CYS A 245E 1555 1555 2.02 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.04 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.03 SSBOND 7 CYS B 22 CYS B 157 1555 1555 2.04 SSBOND 8 CYS B 42 CYS B 58 1555 1555 2.03 SSBOND 9 CYS B 91 CYS B 245E 1555 1555 2.03 SSBOND 10 CYS B 136 CYS B 201 1555 1555 2.04 SSBOND 11 CYS B 168 CYS B 182 1555 1555 2.03 SSBOND 12 CYS B 191 CYS B 220 1555 1555 2.04 LINK C3 0GJ A 1 NE2 HIS A 57 1555 1555 1.49 LINK C2 0GJ A 1 OG SER A 195 1555 1555 1.44 LINK C3 0GJ B 1 NE2 HIS B 57 1555 1555 1.49 LINK C2 0GJ B 1 OG SER B 195 1555 1555 1.42 CISPEP 1 HIS A 218 PRO A 219 0 0.02 CISPEP 2 HIS B 218 PRO B 219 0 -0.91 SITE 1 AC1 9 HIS A 57 ASP A 189 THR A 190 PHE A 193 SITE 2 AC1 9 SER A 195 SER A 214 GLY A 216 GLY A 217 SITE 3 AC1 9 CYS A 220 SITE 1 AC2 12 HIS B 57 ASP B 189 THR B 190 PHE B 193 SITE 2 AC2 12 ASP B 194 SER B 195 SER B 214 GLY B 216 SITE 3 AC2 12 GLY B 217 CYS B 220 HOH B 482 HOH B 634 SITE 1 A 3 HIS A 57 ASP A 102 SER A 195 SITE 1 B 3 HIS B 57 ASP B 102 SER B 195 CRYST1 45.290 67.420 163.670 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022080 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014832 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006110 0.00000